References
- D.J.Newman and M.Cragg, J. Nat. Prod.75, 311 (2012)
- W.H.Gerwick and S.Moore, Chem. Biol.19, 85 (2012)
- W.Bergmann and J.Feeney, J. Org. Chem.16, 981 (1951)
- D.J.Newman, G.M.Cragg, and N.Battershill, Diving. Hyperb. Med.39, 216 (2009)
- W.B.Parker, Chem. Rev.109, 2880 (2009)
- Cancer Drug Information: Cytarabine. Washington: National Cancer Institute; [cited 2014 May 29]. Available from: http://www.cancer.gov/cancertopics/ druginfo/ cytarabine.
- B.S.Chhikara and K.Parang, Expert Opin. Drug Deliv.7, 1399 (2010)
- K.I.Kim, I.S.Huh, I.W.Kim, T.Park, K.S.Ahn, S.S.Yoon, J.H.Yoon, and J.M.Oh, Eur. J. Cancer.49, 403 (2013)
- M.Saneyoshi, M.Morozumi, K.Kodama, H.Machida, A.Kuninaka, and H.Yoshino, Chem. Pharm. Bull.28, 2915 (1980)
- E.Schleyer, J.Braess, B.Ramsauer, M.Unterhalt, C.Kaufmann, S.Wilde, M.Schüssler, and W.Hiddemann, Leukemia9, 1085 (1995)
- T.Ueda, K.Kamiya, Y.Urasaki, S.Wataya, Y.Kawai, H.Tsutani, M.Sugiyama, and T.Nakamura, Cancer Res.54, 109 (1994)
- A.Hamada, T.Kawaguchi, and M.Nakano, Clin. Pharmacokinet.41, 705 (2002)
- M.Aoshima, S.Tsukagoshi, Y.Sakurai, J.Oh-ishi, T.Ishida, and H.Kobayashi, Cancer Res.36, 2726 (1976)
- M.Aoshima, S.Tsukagoshi, Y.Sakurai, J.Oh-ishi, T.Ishida, and H.Kobayashi, Cancer Res.37, 2481 (1977)
- T.Ueda, T.Nakamura, S.Ando, D.Kagawa, M.Sasada, H.Uchino, I.Johno, and Y.Akiyama, Cancer Res.43, 3412 (1983)
- K.Kimura, R.Ohno, I.Amaki, K.Hattori, Y.Hirota, A.Hoshino, M.Ichimaru, M.Ito, I.Kimura, and T.Maekawa, Cancer56, 1913 (1985)
- A.Hoshi, F.Kanzawa, M.Iigo, and K.Kuretani, Gan.66, 539 (1975)
- A.E.Wright, D.A.Forleo, G.P.Gunawardana, S.P.Gunasekera, F.E.Koehn, and O.J.McConnell, J. Org. Chem.55, 4508 (1990)
- Y.Pommier, G.Kohlhagen, C.Bailly, M.Waring, A.Mazumder, and K.W.Kohn, Biochemistry35, 13303 (1996)
- C.Cuevas, M.Pérez, M.J.Martín, J.L.Chicharro, C.Fernández-Rivas, M.Flores, A.Francesch, P.Gallego, M.Zarzuelo, and F.de la Calle, Org. Lett.2, 2545 (2000)
- J.H.Beumer, J.M.Rademaker-Lakhai, H.Rosing, M.J.Hillebrand, T.M.Bosch, L.Lopez-Lazaro, J.H.Schellens, and J.H.Beijnen, Cancer Chemoth. Pharm.59, 825 (2007)
- E.Izbicka, R.Lawrence, E.Raymond, G.Eckhardt, G.Faircloth, J.Jimeno, G.Clark, and D.Von Hoff, Ann. Oncol.9, 981 (1998)
- Yondelis. Auckland: Drugs.com; [cited 2014 May 29]. Available from: http://www.drugs.com/uk/yondelis.html.
- FDA Issues Complete Response Letter for Trabectedin Combined With DOXIL. New Brunswick: Johnson–Johnson; [cited 2014 May 29]. Available from: http:// www.jnj.com/connect/news/all/20090910_130000..
- K.L.Tedesco, J.L.Blum, A.Goncalves, J.Lubinski, N.Ben-Baruch, C.R.Osborne, P.Lardelli, J.C.Tercero, F.A.Holmes, and S.Delaloge, J. Clin. Oncol.28, 1038 (2010)
- K.L.Tedesco, J.L.Blum, A.Goncalves, J.Lubinski, C.R.C.Osborne, P.Lardelli, J.C.Tercero, A.Flores, F.A.Holmes, and S.Delaloge, J. Clin. Oncol.29, 1125 (2011)
- M.Michaelson, J.Bellmunt, G.Hudes, S.Goel, R.Lee, P.Kantoff, C.Stein, P.Lardelli, I.Pardos, and C.Kahatt, Ann. Oncol.23, 1234 (2012)
- L.Gore, E.Rivera, M.Basche, S.L.Moulder-Thompson, J.Li, S.Eppers, S.Grolnic, C.O'Bryant, D.Cleere, Y.A.Elsayed, and G.S.Eckhardt, Invest New Drug.30, 1942 (2012)
- B.Massuti, M.Cobo, C.Camps, M.Dómine, M.Provencio, V.Alberola, N.Viñolas, R.Rosell, M.Tarón, and V.Gutiérrez-Calderón, Lung Cancer.76, 354 (2012)
- J.Y.Blay, Eur. J. Clin. Med.2, 1 (2010)
- M.D'Incalci and C.M.Galmarini, Mol. Cancer Ther.9, 2157 (2010)
- M.Bonfanti, E.La Valle, G.Faircloth, G.Caretti, R.Mantovani, and M.DIncalci, Anticancer Drug Des.14, 179 (1999)
- G.Germano, R.Frapolli, M.Simone, M.Tavecchio, E.Erba, S.Pesce, F.Pasqualini, F.Grosso, R.Sanfilippo, and P.G.Casali, Cancer Res.70, 2235 (2010)
- D.G.Soares, M.S.Machado, C.J.Rocca, V.Poindessous, D.Ouaret, A.Sarasin, C.M.Galmarini, J.A.Henriques, A.E.Escargueil, and A.K.Larsen, Mol. Cancer Ther.10, 1481 (2011)
- Products. Madrid: PharmaMar; [cited 2014 May 29]. Available from: http://www.pharmamar.com/pm01183- en.aspx.
- E.J.Martinez, T.Owa, S.L.Schreiber, and E.Corey, Proc. Natl. Acad. Sci.96, 3496 (1999)
- Z.Z.Liu, Y.Wang, Y.F.Tang, S.Z.Chen, X.G.Chen, and H.Y.Li, Bioorg. Med. Chem. Lett.16, 1282 (2006)
- J.Harris, Micron.30, 597 (1999)
- R.D.Swerdlow, R.F.Ebert, P.Lee, C.Bonaventura, and K.I.Miller, Comp. Biochem. Physiol., B: Biochem. Mol. Biol.113, 537 (1996)
- C.Gatsogiannis and J.Markl, J. Mol. Biol.385, 963 (2009)
- M.E.Cuff, K.I.Miller, K.E.van Holde, and W.A.Hendrickson, J. Mol. Biol.278, 855 (1998)
- C.A.Olsson, R.Chute, and C.N.Rao, J. Urol.111, 173 (1974)
- Keyhole Limpet Hemocyanin. Carlsbad: Biosyn; [cited 2014 June 29]. Available from: http://www.biosyncorp.com/bc_seiten/bc_products.html.
- I.Wirguin, L.Suturkova-Milosević, C.Briani, and N.Latov, Cancer Immunol. Immunother.40, 307 (1995)
- S.Adluri, T.Gilewski, S.Zhang, V.Ramnath, G.Ragupathi, and P.Livingston, Br. J. Cancer.79, 1806 (1999)
- G.Ragupathi, L.Howard, S.Cappello, R.R.Koganty, D.Qiu, B.M.Longenecker, M.A.Reddish, K.O.Lloyd, and P.O.Livingston, Cancer Immunol. Immunother.48, 1 (1999)
- P.Livingston, S.Zhang, S.Adluri, T.J.Yao, L.Graeber, G.Ragupathi, F.Helling, and M.Fleisher, Cancer Immunol. Immunother.43, 324 (1997)
- M.H.Ravindranath, M.C.Kelley, R.C.Jones, A.A.Amiri, P.M.Bauer, and D.L.Morton, Int. J. Cancer.75, 117 (1998)
- T.A.Gilewski, G.Ragupathi, M.Dickler, S.Powell, S.Bhuta, K.Panageas, R.R.Koganty, J.Chin-Eng, C.Hudis, and L.Norton, Clin. Cancer Res.13, 2977 (2007)
- T.D.Terhune and R.C.Deth, J. Immunotoxicol.10, 210 (2013)
- S.Arancibia, C.Espinoza, F.Salazar, M.Del Campo, R.Tampe, T.Y.Zhong, P.De Ioannes, B.Moltedo, J.Ferreira, and E.C.Lavelle, PloS one.9, 1 (2014)
- M. Becker, S. Arancibia, E. Cecilia, F. Salazar, and A. De Ioannes, Novel hemocyanin from the Fissurella latimarginata exhibits an outstanding immunogenicity and non-specific immunomodulatory effects in a melanoma mode. 99th Annual Meeting of the American-Association-of-Immunologists; 2012 May 188; Boston, US (2012)
- S.Arancibia, C.Espinoza, M.Del Campo, F.Salazar, and M.I.Becker, J. Immunother.33, 891 (2010)
- P.Dolashka-Angelova, T.Stefanova, E.Livaniou, L.Velkova, P.Klimentzou, S.Stevanovic, B.Salvato, H.Neychev, and W.Voelter, Immunol. Invest.37, 822 (2008)
- R.Sakai, K.L.Rinehart, V.Kishore, B.Kundu, G.Faircloth, J.B.Gloer, J.R.Carney, M.Namikoshi, F.Sun, and R.G.Hughes, J. Med. Chem.39, 2819 (1996)
- M.Hossain, D.Van der Helm, J.Antel, G.Sheldrick, S.Sanduja, and A.Weinheimer, Proc. Natl. Acad. Sci.85, 4118 (1998)
- H.Kessler, M.Will, J.Antel, H.Beck, and G.M.Sheldrick, Helv. Chim. Acta72, 530 (1989)
- S.B.Bravo, M.E.García-Rendueles, R.Seoane, V.Dosil, J.Cameselle-Teijeiro, L.López-Lázaro, J.Zalvide, F.Barreiro, C.M.Pombo, and C.V.Álvarez, Clin. Cancer Res.11, 7664 (2005)
- M.Broggini, S.Marchini, E.Galliera, P.Borsotti, G.Taraboletti, E.Erba, M.Sironi, J.Jimeno, G.Faircloth, and R.Giavazzi, Leukemia17, 52 (2003)
- N.M.Barboza, D.J.Medina, T.Budak-Alpdogan, M.Aracil, J.M.Jimeno, J.R.Bertino, and D.Banerjee, Cancer Biol. Ther.13, 114 (2012)
- M.J.Muñoz-Alonso, L.González-Santiago, N.Zarich, T.Martínez, E.Alvarez, J.M.Rojas, and A.Muñoz, J. Pharmacol. Exp. Ther.324, 1093 (2008)
- A.Danu, C.Willekens, and V.Ribrag, Expert Opin Orphan Drugs.1, 569 (2013)
- R.K.Jha and Z.R.Xu, Mar. Drugs.2, 123 (2004)
- A.Kijjoa and P.Sawangwong, Mar. Drugs.2, 73 (2004)
- M.J.Muñoz-Alonso, L.González-Santiago, T.Martínez, A.Losada, C.M.Galmarini, and A.Muñoz, Curr. Opin. Invest. Drugs.10, 536 (2009)
- Y.Suárez, L.González-Santiago, N.Zarich, A.Dávalos, J.F.Aranda, M.A.Alonso, M.A.Lasunción, J.M.Rojas, and A.Muñoz, Mol. Pharmacol.70, 1654 (2006)
- A.Cuadrado, L.Gonzalez, K.Nakayama, K.I.Nakayama, J.M.Fernandez-Sousa, A.Munoz, and J.M.Sanchez-Puelles, Oncogene21, 7533 (2002)
- C.M.Crews, J.L.Collins, W.S.Lane, M.L.Snapper, and S.L.Schreiber, J. Biol. Chem.269, 15411 (1994)
- K.L.Rinehart, A.J.. US Patent WO 1,998,017,275 A1. (30 April 1998) Katauskas.
- V.P.Gullo, J.McAlpine, K.S.Lam, D.Baker, and F.Petersen, J. Ind. Microbiol. Biotechnol.33, 523 (2006)
- W.Fenical, P.R.Jensen, M.A.Palladino, K.S.Lam, G.K.Lloyd, and B.C.Potts, Bioorg. Med. Chem.17, 2175 (2009)
- R.H.Feling, G.O.Buchanan, T.J.Mincer, C.A.Kauffman, P.R.Jensen, and W.Fenical, Angew. Chem. Int. Ed.42, 355 (2003)
- V.R.Macherla, S.S.Mitchell, R.R.Manam, K.A.Reed, T.H.Chao, B.Nicholson, G.Deyanat-Yazdi, B.Mai, P.R.Jensen, and W.F.Fenical, J. Med. Chem.48, 3684 (2005)
- D.Chauhan, T.Hideshima, and K.Anderson, Br. J. Cancer.95, 961 (2006)
- C.M.Sloss, F.Wang, R.Liu, L.Xia, M.Houston, D.Ljungman, M.A.Palladino, and J.C.Cusack, Clin. Cancer Res.14, 5116 (2008)
- M.Millward, T.Price, A.Townsend, C.Sweeney, A.Spencer, S.Sukumaran, A.Longenecker, L.Lee, A.Lay, and G.Sharma, Invest New Drugs.30, 2303 (2012)
- A.F.Kisselev and A.L.Goldberg, Chem. Biol.8, 739 (2001)
- B.Potts, M.Albitar, K.Anderson, S.Baritaki, C.Berkers, B.Bonavida, J.Chandra, D.Chauhan, J.CusackJr., and W.Fenical, Curr. Cancer Drug Targets11, 254 (2011)
- K.S.Ahn, G.Sethi, T.H.Chao, S.T.Neuteboom, M.M.Chaturvedi, M.A.Palladino, A.Younes, and B.B.Aggarwal, Blood110, 2286 (2007)
- M.Stadler, J.Bitzer, A.Mayer-Bartschmid, H.Müller, J.Benet-Buchholz, F.Gantner, H.V.Tichy, P.Reinemer, and K.B.Bacon, J. Nat. Prod.70, 246 (2007)
- M.Groll and B.C.Potts, Curr. Top. Med. Chem.11, 2850 (2011)
- S.H. Neuss, O.G. Leverkusen, W.W. wermelskirchen, K.K. Dusseldorf, A.U. Leverkusen, A.M. Langenfeld, P.S. Koln, U.W. Neuwied, K.K. Langenfeld, P.L. Leverkusen, O.M. Rosrath, P.R. Munchen, M.S. Wuppertal, S.S. Schwelm, A.M. Wulfrath, H.M. Velbert, K.B. Kobe, M.W. Langenfeld, and K.I. Koln, Substituted 2-pyrrolidone derivatives as fungicides and insecticides. Unite States Patent US 2008/0064736 A1. 2008 March 13 (2008)
- R.R.Manam, S.Teisan, D.J.White, B.Nicholson, J.Grodberg, S.T.Neuteboom, K.S.Lam, D.A.Mosca, G.K.Lloyd, and B.C.Potts, J. Nat. Prod.68, 240 (2005)
- C.Olano, C.Méndez, and J.A.Salas, Mar. Drugs7, 210 (2009)
- J.Cortes, A.J.Montero, and S.Glück, Cancer Treat Rev.38, 143 (2012)
- M.J.Towle, K.A.Salvato, J.Budrow, B.F.Wels, G.Kuznetsov, K.K.Aalfs, S.Welsh, W.Zheng, B.M.Seletsky, and M.H.Palme, Cancer Res.61, 1013 (2001)
- T.K.Huyck, W.Gradishar, F.Manuguid, and P.Kirkpatrick, Nat. Rev. Drug.10, 173 (2011)
- B.M.Seletsky, Y.Wang, L.D.Hawkins, M.H.Palme, G.J.Habgood, L.V.DiPietro, M.J.Towle, K.A.Salvato, B.F.Wels, and K.K.Aalfs, Bioorg. Med. Chem. Lett.14, 5547 (2004)
- S.L.Scarpace, Clin. Ther.34, 1467 (2012)
- J.Cortes and R.Lorca, Future Oncol.7, 355 (2011)
- FDA Approval for Eribulin Mesylate. Bethesda: National Cancer Institute; [cited 2014 June 13]. Available from: http://www.cancer.gov/cancertopics/druginfo/fda-eribulinmesylate.
- K.L.Jackson, J.A.Henderson, and A.J.Phillips, Chem. Rev.109, 3044 (2009)
- M.A.Jordan, K.Kamath, T.Manna, T.Okouneva, H.P.Miller, C.Davis, B.A.Littlefield, and L.Wilson, Mol. Cancer Ther.4, 1086 (2005)
- D.A.Dabydeen, J.C.Burnett, R.Bai, P.Verdier-Pinard, S.J.Hickford, G.R.Pettit, J.W.Blunt, M.H.Munro, R.Gussio, and E.Hamel, Mol. Pharmacol.70, 1866 (2006)
- J.H.Lin and M.Yamazaki, Drug Metab Rev.35, 417 (2003)
- K.Goda, Z.Bacso, and G.Szabo, Curr. Cancer Drug Targets.9, 281 (2009)
- S.Narayan, E.M.Carlson, H.Cheng, K.Condon, H.Du, S.Eckley, Y.Hu, Y.Jiang, V.Kumar, and B.M.Lewis, Bioorg. Med. Chem. Lett.21, 1634 (2011)
- Y.Hayashi, B.Nicholson, K.Tanaka, A.Oda, G.K.Lloyd, M.Akamatsu, M.A.Palladino, and Y.Kiso, Peptide Sci.41, 405 (2005)
- K.Kanoh, S.Kohno, T.Asari, T.Harada, J.Katada, M.Muramatsu, H.Kawashima, H.Sekiya, and I.Uno, Bioorg. Med. Chem. Lett.7, 2847 (1997)
- W.Fenical, P.R.Jensen, X.C.. US Patent 6,069,146 A. (30 May 2000) Cheng, (2000)
- B.Nicholson, G.K.Lloyd, B.R.Miller, M.A.Palladino, Y.Kiso, Y.Hayashi, and S.T.Neuteboom, Anticancer Drug Des.17, 25 (2006)
- M.Millward, A.Mita, M.Spear, K.Federico, G.Lloyd, G.Cropp, M.Mita, and P.Mainwaring, J. Clin. Oncol.27, 3571 (2009)
- A.V.Singh, M.Bandi, N.Raje, P.Richardson, M.A.Palladino, D.Chauhan, and K.C.Anderson, Blood117, 5692 (2011)
- Y.Yamazaki, M.Sumikura, K.Hidaka, H.Yasui, Y.Kiso, F.Yakushiji, and Y.Hayashi, Bioorg. Med. Chem.18, 3169 (2010)
- M.M.Mita, M.A.Spear, L.K.Yee, A.C.Mita, E.I.Heath, K.P.Papadopoulos, K.C.Federico, S.D.Reich, O.Romero, and L.Malburg, Clin. Cancer Res.16, 5892 (2010)
- F.Yakushiji, H.Tanaka, K.Muguruma, T.Iwahashi, Y.Yamazaki, and Y.Hayashi, Chem.-Eur. J.17, 12587 (2011)
- Y.Yamazaki, K.Tanaka, B.Nicholson, G.Deyanat-Yazdi, B.Potts, T.Yoshida, A.Oda, T.Kitagawa, S.Orikasa, and Y.Kiso, J. Med. Chem.55, 1056 (2012)
- S.L.Wehrli, K.S.Moore, H.Roder, S.Durell, and M.Zasloff, Steroids58, 370 (1993)
- D.Panda, V.Ananthnarayan, G.Larson, C.Shih, M.A.Jordan, and L.Wilson, Biochemistry.39, 14121 (2000)
- M.Martínez-Díez, M.J.Guillén-Navarro, B.Pera, B.P.Bouchet, J.F.Martínez-Leal, I.Barasoain, C.Cuevas, J.M.Andreu, L.F.García-Fernández, and J.F.Díaz, Biochem. Pharmacol.88, 291 (2014)
- Y.Murti and T.Agrawal, Int. J. ChemTech Res.2, 2198 (2010)
- P.Schöffski, H.Dumez, R.Ruijter, B.Miguel-Lillo, A.Soto-Matos, V.Alfaro, and G.Giaccone, Cancer Chemother. Pharmacol.68, 1397 (2011)
- J.Katz, J.E.Janik, and A.Younes, Clin. Cancer Res.17, 6428 (2011)
- F.Loganzo, C.M.Discafani, T.Annable, C.Beyer, S.Musto, M.Hari, X.Tan, C.Hardy, R.Hernandez, and M.Baxter, Cancer Res.63, 1838 (2003)
- A.Zask, J.Kaplan, S.Musto, and F.Loganzo, J. Am. Chem. Soc.127, 17667 (2005)
- L.J.Cruz, J.R.Luque-Ortega, L.Rivas, and F.Albericio, Mol. Pharm.6, 813 (2009)
- Y.H.Ling, M.Aracil, Y.Zou, Z.Yuan, B.Lu, J.Jimeno, A.M.Cuervo, and R.Perez-Soler, Clin. Cancer Res.17, 5353 (2011)
- Z.Cruz-Monserrate, J.T.Mullaney, P.G.Harran, G.R.Pettit, and E.Hamel, Eur. J. Biochem.270, 3822 (2003)
- T.L.Simmons, E.Andrianasolo, K.McPhail, P.Flatt, and W.H.Gerwick, Mol. Cancer Ther4, 333 (2005)
- A.Ray, T.Okouneva, T.Manna, H.P.Miller, S.Schmid, L.Arthaud, R.Luduena, M.A.Jordan, and L.Wilson, Cancer Res.67, 3767 (2007)
- K.L.Desjardine, Bioactive Marine Natural Prouducts (University of British Columbia, Vancouver, 2007)
- A.Mai, S.Massa, R.Pezzi, S.Valente, P.Loidl, and G.Brosch, Med. Chem.1, 245 (2005)
- T.L.Sinnons, E.Andrianasolo, K.McPhail, P.Flatt, and W.H.Gerwick, Mol. Cancer Ther.4, 333 (2005)